Clene Inc Share Price Today: Live Updates & Key Insights

Clene Inc share price today is $5.22, up -9.28%. The stock opened at $5.88 against the previous close of $5.87, with an intraday high of $5.9926 and low of $5.25.

Clene Inc Share Price Chart

Clene Inc

us-stock
To Invest in {{usstockname}}
us-stock

Clene Inc Share Price Performance

$5.22 -0.0928(-9.28%) CLNN at 23 Mar 2026 12:29 PM Packaged Foods
Lowest Today 5.25
Highest Today 5.9926
Today’s Open 5.88
Prev. Close 5.87
52 Week High 13.50
52 Week Low 2.28
Day’s Range: Low 5.25 High 5.9926
52-Week Range: Low 2.28 High 13.50
1 day return -
1 Week return -11.71
1 month return +18.37
3 month return -14.96
6 month return -16.69
1 year return +31.55
3 year return +366.22
5 year return -61.89
10 year return -

Clene Inc Institutional Holdings

NT Ext Equity Mkt Idx Fd - DC - NL - T2 1.81

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.65

BNYM Mellon SL Market Completion UC1 0.16

BNYM Mellon NSL Mkt Completion Fund Inst 0.01

Clene Inc Market Status

Strong Buy: 3

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Clene Inc Fundamentals

Market Cap 62.72 M

PB Ratio 7.8325

PE Ratio 0.0

Enterprise Value 79.32 M

Total Assets 18.13 M

Volume 152105

Clene Inc Company Financials

Annual Revenue FY23:718000 0.7M, FY22:473000 0.5M, FY21:723000 0.7M, FY20:206000 0.2M, FY19:0 0.0M

Annual Profit FY23:628000 0.6M, FY22:447000 0.4M, FY21:434000 0.4M, FY20:141000 0.1M, FY19:0 0.0M

Annual Net worth FY23:-40385000 -40.4M, FY22:-15279000 -15.3M, FY21:-9740000 -9.7M, FY20:-19277000 -19.3M, FY19:-16270000 -16.3M

Quarterly Revenue Q3/2025:15000 0.0M, Q2/2025:27000 0.0M, Q1/2025:81000 0.1M, Q3/2024:87000 0.1M, Q2/2024:91000 0.1M

Quarterly Profit Q3/2025:15000 0.0M, Q2/2025:27000 0.0M, Q1/2025:61000 0.1M, Q3/2024:69000 0.1M, Q2/2024:73000 0.1M

Quarterly Net worth Q3/2025:-8777000 -8.8M, Q2/2025:-7419000 -7.4M, Q1/2025:-751000 -0.8M, Q3/2024:-7986000 -8.0M, Q2/2024:-6785000 -6.8M

About Clene Inc & investment objective

Company Information Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. It develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, the company markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. Clene Inc. is headquartered in Salt Lake City, Utah.

Organisation Packaged Foods

Employees 75

Industry Packaged Foods

CEO Mr. Robert Etherington MBA

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Clene Inc FAQs

What is the share price of Clene Inc today?

The current share price of Clene Inc is $5.22.

Can I buy Clene Inc shares in India?

Yes, Indian investors can buy Clene Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Clene Inc shares in India?

You can easily invest in Clene Inc shares from India by:

Can I buy fractional shares of Clene Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Clene Inc?

Clene Inc has a market cap of $62.72 M.

In which sector does Clene Inc belong?

Clene Inc operates in the Packaged Foods sector.

What documents are required to invest in Clene Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Clene Inc?

The PE ratio of Clene Inc is N/A and the PB ratio is 7.83.